Clinical Trial Update: Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing lot-to-lot consistency for the Japanese Encephalitis live attenuated SA 14-14-2 vaccine; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• SA 14-14-2 live attenuated vaccine (live attenuated Japanese encephalitis vaccine SA 14-14-2)

Snippet

Sponsor: PATH | Conditions: Japanese Encephalitis | Phase 4 | Status: COMPLETED | Results posted: 2018-11-13